Image: StatnewsA breakthrough pancreatic cancer drug won approval. They still struggle to access it
• The FDA approved Rasonque, a new pancreatic cancer drug developed by Revolution Medicines. • Patients seeking the treatment have found that insurance coverage can take several weeks to catch up with the official approval. • This delay prevents eligible patients from accessing a breakthrough medication during a critical window of their illness.
statnews.com





